Metropolis Healthcare Ltd. got a buy recommendation from The Street Fund Manager & Trading Strategist Kunal Rambhia. The target price for the stock is Rs 1,800 apiece, which implies a 5.3% upside from Tuesday's close price. The stop loss is at Rs 1,690 apiece.
Out of 24 analysts tracking the company, 18 maintain a 'buy' rating, two recommend a 'hold', and four suggest 'sell', according to Bloomberg data. The average 12-month consensus price target implies an upside of 12.5%.
